Fangsheng Fu

Guangxi Key Laboratory Of Regenerative Medicine
Nanning, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Tiliroside is a new potential therapeutic drug for osteoporosis in mice.

Tiliroside is a new potential therapeutic drug for osteoporosis in mice.

Journal: Journal of cellular physiology

Published: February 06, 2024

Chrysin Protects Against Titanium Particle-Induced Osteolysis by Attenuating Osteoclast Formation and Function by Inhibiting NF-κB and MAPK Signaling.

Chrysin Protects Against Titanium Particle-Induced Osteolysis by Attenuating Osteoclast Formation and Function by Inhibiting NF-κB and MAPK Signaling.

Journal: Frontiers in pharmacology

Published: October 11, 2021

Ellagic acid protects ovariectomy-induced bone loss in mice by inhibiting osteoclast differentiation and bone resorption.

Ellagic acid protects ovariectomy-induced bone loss in mice by inhibiting osteoclast differentiation and bone resorption.

Journal: Journal of cellular physiology

Published: May 20, 2019

Daphnetin attenuates LPS-induced osteolysis and RANKL mediated osteoclastogenesis through suppression of ERK and NFATc1 pathways.

Daphnetin attenuates LPS-induced osteolysis and RANKL mediated osteoclastogenesis through suppression of ERK and NFATc1 pathways.

Journal: Journal of cellular physiology

Published: December 07, 2018

Tiliroside is a new potential therapeutic drug for osteoporosis in mice.

Tiliroside is a new potential therapeutic drug for osteoporosis in mice.

Journal: Journal of cellular physiology

Published: November 26, 2018

Pectolinarigenin prevents bone loss in ovariectomized mice and inhibits RANKL-induced osteoclastogenesis via blocking activation of MAPK and NFATc1 signaling.

Pectolinarigenin prevents bone loss in ovariectomized mice and inhibits RANKL-induced osteoclastogenesis via blocking activation of MAPK and NFATc1 signaling.

Journal: Journal of cellular physiology

Published: November 13, 2018

Salidroside promotes rat spinal cord injury recovery by inhibiting inflammatory cytokine expression and NF-κB and MAPK signaling pathways.

Salidroside promotes rat spinal cord injury recovery by inhibiting inflammatory cytokine expression and NF-κB and MAPK signaling pathways.

Journal: Journal of cellular physiology

Published: November 12, 2018

Diosmetin inhibits osteoclast formation and differentiation and prevents LPS-induced osteolysis in mice.

Diosmetin inhibits osteoclast formation and differentiation and prevents LPS-induced osteolysis in mice.

Journal: Journal of cellular physiology

Published: September 09, 2018

Scutellarein inhibits RANKL-induced osteoclast formation in vitro and prevents LPS-induced bone loss in vivo.

Scutellarein inhibits RANKL-induced osteoclast formation in vitro and prevents LPS-induced bone loss in vivo.

Journal: Journal of cellular physiology

Published: September 07, 2018

Showing 1-9 of 9

Last Updated: 09/26/2026